10x Genomics Precio/Ventas
¿Qué es el Precio/Ventas de 10x Genomics?
El Precio/Ventas de 10x Genomics, Inc. es 6.33
¿Cuál es la definición de Precio/Ventas?
El ratio precio / ventas es el precio de las acciones de una empresa en comparación con sus ingresos.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Precio/Ventas de compañías en Sector Health Care en NASDAQ en comparadas con 10x Genomics
¿Qué hace 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Empresas con precio/ventas similar a 10x Genomics
- London Stock Exchange plc tiene Precio/Ventas de 6.32
- Agilysys, Inc tiene Precio/Ventas de 6.32
- CG Power and Industrial Solutions tiene Precio/Ventas de 6.33
- Sprott Physical Silver Trust tiene Precio/Ventas de 6.33
- Northview Apartment Real Estate Investment Trust tiene Precio/Ventas de 6.33
- ITI tiene Precio/Ventas de 6.33
- 10x Genomics tiene Precio/Ventas de 6.33
- Redsun Services tiene Precio/Ventas de 6.34
- co.don AG tiene Precio/Ventas de 6.34
- Arista Networks Inc tiene Precio/Ventas de 6.34
- Langham Hospitality Investments tiene Precio/Ventas de 6.35
- Ascencio SCA tiene Precio/Ventas de 6.35
- Hindustan Oil Exploration tiene Precio/Ventas de 6.35